CN104026446B - 一种适合于高血糖人群服用的营养代餐粉及其制备方法 - Google Patents
一种适合于高血糖人群服用的营养代餐粉及其制备方法 Download PDFInfo
- Publication number
- CN104026446B CN104026446B CN201410204467.8A CN201410204467A CN104026446B CN 104026446 B CN104026446 B CN 104026446B CN 201410204467 A CN201410204467 A CN 201410204467A CN 104026446 B CN104026446 B CN 104026446B
- Authority
- CN
- China
- Prior art keywords
- powder
- meal replacement
- nutritional meal
- hyperglycemia population
- replacement powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims abstract description 94
- 235000012054 meals Nutrition 0.000 title claims abstract description 32
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 28
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 235000013311 vegetables Nutrition 0.000 claims abstract description 13
- 239000000835 fiber Substances 0.000 claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 239000011782 vitamin Substances 0.000 claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 12
- 229930003231 vitamin Natural products 0.000 claims abstract description 12
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 10
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 10
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 10
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 10
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 10
- 239000002131 composite material Substances 0.000 claims abstract description 10
- -1 compound vitamin Chemical class 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 229940013618 stevioside Drugs 0.000 claims abstract description 10
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019202 steviosides Nutrition 0.000 claims abstract description 10
- 239000000413 hydrolysate Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 18
- 230000001954 sterilising effect Effects 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 13
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 229930013930 alkaloid Natural products 0.000 claims description 8
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 240000000249 Morus alba Species 0.000 claims description 7
- 235000008708 Morus alba Nutrition 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 244000077995 Coix lacryma jobi Species 0.000 claims description 5
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 5
- 240000008067 Cucumis sativus Species 0.000 claims description 5
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 5
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 4
- 241000581835 Monodora junodii Species 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000003345 hyperglycaemic effect Effects 0.000 abstract description 3
- 235000008935 nutritious Nutrition 0.000 abstract description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 239000003814 drug Substances 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical group O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 description 5
- 229960002632 acarbose Drugs 0.000 description 5
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 5
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229960001052 streptozocin Drugs 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 235000019890 Amylum Nutrition 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000013118 diabetic mouse model Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical group 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410204467.8A CN104026446B (zh) | 2014-05-15 | 2014-05-15 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410204467.8A CN104026446B (zh) | 2014-05-15 | 2014-05-15 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104026446A CN104026446A (zh) | 2014-09-10 |
CN104026446B true CN104026446B (zh) | 2016-08-24 |
Family
ID=51457614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410204467.8A Active CN104026446B (zh) | 2014-05-15 | 2014-05-15 | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104026446B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106539096A (zh) * | 2016-10-21 | 2017-03-29 | 陕西科技大学 | 一种能降低餐后血糖的方便早餐粉 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104473152A (zh) * | 2014-11-19 | 2015-04-01 | 石泽 | 一种相当于拜糖平的物理方法降低餐后血糖的生物药膳 |
CN104489697A (zh) * | 2014-12-19 | 2015-04-08 | 成都永安制药有限公司 | 一种含有低聚甘露糖的具有保健功能的代餐粉及其制备方法 |
CN106135791A (zh) * | 2015-03-25 | 2016-11-23 | 天津阿尔发保健品有限公司 | 一种强化营养的降糖特膳即食谷物粉 |
CN105410689A (zh) * | 2015-10-27 | 2016-03-23 | 广东省农业科学院蚕业与农产品加工研究所 | 适合糖尿病肾病营养模式的特殊膳食用食品及其制作方法 |
CN105341923A (zh) * | 2015-11-23 | 2016-02-24 | 黄山学院 | 一种富硒减肥代餐食品及其制备方法 |
CN106605822A (zh) * | 2016-12-19 | 2017-05-03 | 西安源森生物科技有限公司 | 一种有利于降血糖的组合物及其制备方法 |
CN106819993B (zh) * | 2017-01-06 | 2020-05-05 | 山东省内分泌与代谢病研究所 | 一种多功能魔芋代餐粉的制备方法 |
CN106889626A (zh) * | 2017-03-01 | 2017-06-27 | 王厚淇 | 一种苹果水溶性膳食纤维代餐粉及其制备方法 |
MX2019012459A (es) * | 2017-04-18 | 2019-12-19 | Purecircle Usa Inc | Composiciones para tratamiento de hiperglucemia en pacientes con diabetes mellitus. |
CN109393309A (zh) * | 2017-08-18 | 2019-03-01 | 浙江野麦实业有限公司 | 一种低gi燕麦代餐粉及其制作方法 |
CN107625121A (zh) * | 2017-09-01 | 2018-01-26 | 徐州工程学院 | 预防心脑血管疾病的全营养果蔬纤维代餐粉 |
CN108208802A (zh) * | 2017-12-31 | 2018-06-29 | 西安凯伦生物科技有限公司 | 一种适合糖尿病患者食用的特殊膳食及其制备方法 |
CN108185343A (zh) * | 2018-02-01 | 2018-06-22 | 齐鲁工业大学 | 一种低热量速溶复合代餐粉及其制备方法 |
CN110574871A (zh) * | 2018-06-11 | 2019-12-17 | 江苏帝尔生物科技有限公司 | 一种能够帮助控制血糖的营养代餐产品及其制备方法 |
CN109221903A (zh) * | 2018-08-31 | 2019-01-18 | 保龄宝生物股份有限公司 | 一种辅助通便和降胆固醇的代餐粉及其制备方法和应用 |
CN112262989A (zh) * | 2020-11-04 | 2021-01-26 | 光瀚健康咨询管理(上海)有限公司 | 一种蛋白控糖代餐粉及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101756133A (zh) * | 2010-01-15 | 2010-06-30 | 深圳市亚泰轩实业有限公司 | 南瓜果蔬早餐配方及加工方法 |
CN102687750A (zh) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | 一种减肥代餐蛋白型固体饮料 |
CN102697060A (zh) * | 2012-05-23 | 2012-10-03 | 广东省农业科学院农业生物技术研究所 | 一种具有辅助降血糖作用的苦瓜营养膳及其制作方法 |
CN103053903A (zh) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | 一种具有降低食物血糖生成指数的复合功能糖 |
CN103081967A (zh) * | 2011-10-31 | 2013-05-08 | 杜方 | 一种复合型膳食纤维饼干 |
CN103222627A (zh) * | 2012-12-12 | 2013-07-31 | 姜峰 | 一种具有防治糖尿病的保健食品 |
CN103300096A (zh) * | 2012-03-14 | 2013-09-18 | 杜方 | 一种复合型膳食纤维威化饼干 |
CN103478527A (zh) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | 一种低血糖生成指数营养粉 |
CN103689565A (zh) * | 2013-11-21 | 2014-04-02 | 广州市体育科学研究所 | 一种减重降脂的植物固体饮料及其制备方法 |
-
2014
- 2014-05-15 CN CN201410204467.8A patent/CN104026446B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101756133A (zh) * | 2010-01-15 | 2010-06-30 | 深圳市亚泰轩实业有限公司 | 南瓜果蔬早餐配方及加工方法 |
CN103081967A (zh) * | 2011-10-31 | 2013-05-08 | 杜方 | 一种复合型膳食纤维饼干 |
CN103300096A (zh) * | 2012-03-14 | 2013-09-18 | 杜方 | 一种复合型膳食纤维威化饼干 |
CN102697060A (zh) * | 2012-05-23 | 2012-10-03 | 广东省农业科学院农业生物技术研究所 | 一种具有辅助降血糖作用的苦瓜营养膳及其制作方法 |
CN102687750A (zh) * | 2012-06-13 | 2012-09-26 | 杭州诺伽特健康科技有限公司 | 一种减肥代餐蛋白型固体饮料 |
CN103222627A (zh) * | 2012-12-12 | 2013-07-31 | 姜峰 | 一种具有防治糖尿病的保健食品 |
CN103053903A (zh) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | 一种具有降低食物血糖生成指数的复合功能糖 |
CN103478527A (zh) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | 一种低血糖生成指数营养粉 |
CN103689565A (zh) * | 2013-11-21 | 2014-04-02 | 广州市体育科学研究所 | 一种减重降脂的植物固体饮料及其制备方法 |
Non-Patent Citations (2)
Title |
---|
桑叶有效成分降糖作用研究;玄光善等;《食品科学》;20110415;第32卷(第7期);第324页左栏 5段,第326页右栏第3段 * |
花青素的生理活性研究进展;徐春明等;《中国食品添加剂》;20130615(第3期);第205-210页 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106539096A (zh) * | 2016-10-21 | 2017-03-29 | 陕西科技大学 | 一种能降低餐后血糖的方便早餐粉 |
Also Published As
Publication number | Publication date |
---|---|
CN104026446A (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104026446B (zh) | 一种适合于高血糖人群服用的营养代餐粉及其制备方法 | |
CN103285231B (zh) | 一种用于糖尿病辅助治疗的药物组合物及其制法 | |
CN106174585A (zh) | 降血糖的组合物及降血糖的复合益生菌特膳食品 | |
CN106666312A (zh) | 一种辅助降血糖的保健食品及其颗粒剂和胶囊剂制备方法 | |
CN111840363B (zh) | 一种纳豆辅助降血糖保健组合物及其制备方法和用途 | |
CN1757317A (zh) | 罗汉果片及其制备工艺 | |
CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
CN103191332A (zh) | 具有健胃消食作用的组合物及保健品 | |
CN105942498A (zh) | 具有治疗糖尿病作用的功能性营养食品组合及其制备方法 | |
CN109393494A (zh) | 一种中老年用保健食品组合物及其应用 | |
CN105148252A (zh) | 一种复方降糖制剂 | |
CN106689959A (zh) | 一种辅助调节血糖的固体饮料 | |
CN105124347A (zh) | 一种辣木降血糖组合物及其制备方法 | |
CN104383259A (zh) | 一种苦瓜桑叶富铬胶囊及其制备方法 | |
CN104187681B (zh) | 一种降血糖降血脂保健食品及其制备方法 | |
CN105341893A (zh) | 一种辅助降血糖的组合物及应用 | |
CN104587429B (zh) | 一种姜蜜炮制西洋参制剂及制备方法 | |
CN105725187A (zh) | 一种降血糖组合物及其用于制备食品和保健食品的用途 | |
CN101904916B (zh) | 治疗糖尿病的药物及其制备方法 | |
CN104825821A (zh) | 一种治疗糖尿病的药物及其制备方法 | |
CN107616491A (zh) | 一种用于防治糖尿病的功能食品 | |
CN102552743A (zh) | 一种用于治疗糖尿病的药物组合物及其制备方法 | |
CN102499366A (zh) | 调节血脂和抗疲劳的保健食品 | |
CN104984102A (zh) | 一种具有降血糖功效的虾青素保健胶囊 | |
CN104187662A (zh) | 一种调理卵巢癌的方便食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140910 Assignee: Shandong Xiajin Gusang Industry Research Institute Co.,Ltd. Assignor: SERICULTURE & AGRI FOOD Research Institute GAAS Contract record no.: X2022440000079 Denomination of invention: A kind of nutritional meal replacement powder suitable for people with hyperglycemia and preparation method thereof Granted publication date: 20160824 License type: Common License Record date: 20220819 |
|
EE01 | Entry into force of recordation of patent licensing contract |